2011
DOI: 10.1016/j.jss.2011.01.042
|View full text |Cite
|
Sign up to set email alerts
|

Pediatric Dermatofibrosarcoma Protuberans: Multi-Institutional Outcomes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

5
26
0

Year Published

2012
2012
2022
2022

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 28 publications
(31 citation statements)
references
References 18 publications
5
26
0
Order By: Relevance
“…In our series, the median age at diagnosis was 15 (IQR 8.5-16), similar to the results of other pediatric series, with a median age at diagnosis of 7 to 16 years (18,19,22). A large series found slight differences in incidence between men and women (2,14,17,21). Girls and boys were affected almost equally in our study.…”
Section: Discussionsupporting
confidence: 90%
See 3 more Smart Citations
“…In our series, the median age at diagnosis was 15 (IQR 8.5-16), similar to the results of other pediatric series, with a median age at diagnosis of 7 to 16 years (18,19,22). A large series found slight differences in incidence between men and women (2,14,17,21). Girls and boys were affected almost equally in our study.…”
Section: Discussionsupporting
confidence: 90%
“…The duration of clinical follow-up in our study (median 70.5 months [IQR 30.7-123.0 months]) was similar to the follow-up periods of other published series of 5.8 years (14). Recurrence rates have been reported to be in the range of 20% to 50%, with the majority of recurrences occurring within the first 3 years after excision (3,16,21), although late relapses may occur (33).…”
Section: Discussionsupporting
confidence: 85%
See 2 more Smart Citations
“…Micrographic control of excision margins improves outcome and reduces recurrence rates while limiting the need of closure by flaps or grafts. 11,[24][25][26] We treated our patient with micrographic controlled surgery (delayed MMS). A regular follow-up is necessary to control the outcome and minimize delay for re-treatment when needed.…”
mentioning
confidence: 99%